Download PDF
Horm Metab Res 2019; 51(03): 178-185
DOI: 10.1055/a-0850-9448
Endocrine Care
© Georg Thieme Verlag KG Stuttgart · New York

Quality of Life but not Cognition is Impacted by Radiotherapy in Patients with Non-Functioning Pituitary Adenoma

Genevieve Crouzeix
1   Department of Endocrinology, University Hospital of Brest, Brest Cedex, France
,
Rémy Morello
2   Department of Biostatistics and Clinical Research, Caen Cedex, France
,
Juliette Thariat
3   Department of Radiation Oncology, Baclesse Cancer Center, Caen Cedex, France
,
Julia Morera
4   Department of Endocrinology and Diabetology, University Hospital of Caen, Caen Cedex, France
,
Michael Joubert
4   Department of Endocrinology and Diabetology, University Hospital of Caen, Caen Cedex, France
5   University of Caen, Medical School, Caen, France
,
Yves Reznik
4   Department of Endocrinology and Diabetology, University Hospital of Caen, Caen Cedex, France
5   University of Caen, Medical School, Caen, France
› Author Affiliations
Further Information

Publication History

received 15 September 2018

accepted 24 January 2019

Publication Date:
12 March 2019 (online)

Also available at
    Permissions and Reprints

Abstract

Non-functioning pituitary adenomas (NFPA) are benign neoplasms that are first treated by surgery and secondary radiation therapy in case of residual tumor or regrowth. The consequences of surgery and radiotherapy are still debated. The objective of the work was to assess the impact of surgery, radiotherapy (RT) and pituitary deficiencies on long term health-related quality of life (QoL) and cognitive function among NFPA patients. Forty-six NFPA patients were studied after 9.6±7.5 years follow-up using: i) the MoCA questionnaire to detect mild cognitive disabilities, ii) the McNair and Kahn scale to assess perceived cognitive impairment, iii) the HADS questionnaire to score anxiety and depression, and iv) the SF-36 and QLS-H questionnaires to assess QoL. All NFPA patients had surgery and 54% patients had radiation therapy (RT+). The MoCA score was abnormal in 41% NFPA patients. Neither the type of surgery nor radiotherapy influenced the prevalence of cognitive disabilities. The depression score was higher in RT+than RT– patients. Overall, no alteration in SF-36 and QLS-H QoL scales were observed in NFPA patients when compared with the French reference population. Among NFPA patients, mental composite score, general health and vitality scores were altered in RT+compared to RT– patients. The presence of multiple pituitary axis deficiencies worsened general health and vitality scale scoring. Consistent follow-up had a beneficial impact on psycho-emotional dimensions of health. Surgery and radiotherapy had no adverse effects on cognitive functions, however, QoL was altered in RT+patients. These latter alterations may be partly related to pituitary hormone deficiencies.

Key words

radiotherapy - surgery - pituitary adenoma - hypopituitarism - cognitive function - quality of life
 

  • References

  • 1 Fernandez A, Karavitaki N, Wass JA. Prevalence of pituitary adenomas: A community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin endocrinol (Oxf) 2010; 72: 377-382
    CrossrefPubMedGoogle Scholar
  • 2 Daly AF, Rixhon M, Adam C. et al. High prevalence of pituitary adenomas: A cross-sectional study in the province of Liege, Belgium. J Clin Endocrinol Metab 2006; 91: 4769-4775
    CrossrefPubMedGoogle Scholar
  • 3 Loeffler JS, Shih HA. Radiation therapy in the management of pituitary adenomas. J Clin Endocrinol Metab 2011; 96: 1992-2003
    CrossrefPubMedGoogle Scholar
  • 4 Castinetti F, Brue T. [Radiotherapy and radiosurgery of pituitary adenomas]. Presse Med 2009; 38: 133-139
    CrossrefPubMedGoogle Scholar
  • 5 Sheehan JP, Starke RM, Mathieu D. et al. Gamma knife radiosurgery for the management of nonfunctioning pituitary adenomas: A multicenter study. J Neurosurg 2013; 119: 446-456
    CrossrefPubMedGoogle Scholar
  • 6 Lee CC, Kano H, Yang HC. et al. Initial gamma knife radiosurgery for nonfunctioning pituitary adenomas. J Neurosurg 2014; 120: 647-654
    CrossrefPubMedGoogle Scholar
  • 7 van Beek AP, van den Bergh AC, van den Berg LM. et al. Radiotherapy is not associated with reduced quality of life and cognitive function in patients treated for nonfunctioning pituitary adenoma. Int J Radiat Oncol Biol Phys 2007; 68: 986-991
    CrossrefPubMedGoogle Scholar
  • 8 Noad R, Narayanan KR, Howlett T. et al. Evaluation of the effect of radiotherapy for pituitary tumours on cognitive function and quality of life. Clin Oncol 2004; 16: 233-237
    CrossrefPubMedGoogle Scholar
  • 9 Guinan EM, Lowy C, Stanhope N. et al. Cognitive effects of pituitary tumours and their treatments: Two case studies and an investigation of 90 patients. J Neurol Neurosurg Psychiatry 1998; 65: 870-876
    CrossrefPubMedGoogle Scholar
  • 10 Peace KA, Orme SM, Padayatty SJ. et al. Cognitive dysfunction in patients with pituitary tumour who have been treated with transfrontal or transsphenoidal surgery or medication. Clin Endocrinol (Oxf) 1998; 49: 391-396
    CrossrefPubMedGoogle Scholar
  • 11 McCord MW, Buatti JM, Fennell EM. et al. Radiotherapy for pituitary adenoma: Long-term outcome and sequelae. Int J Radiat Oncol Biol Phys 1997; 39: 437-444
    CrossrefPubMedGoogle Scholar
  • 12 Dekkers OM, van der Klaauw AA, Pereira AM. et al. Quality of life is decreased after treatment for nonfunctioning pituitary macroadenoma. J Clin Endocrinol Metab 2006; 91: 3364-3369
    CrossrefPubMedGoogle Scholar
  • 13 Mohr G, Hardy J, Comtois R. et al. Surgical management of giant pituitary adenomas. Can J Neurol Sci 1990; 17: 62-66
    CrossrefPubMedGoogle Scholar
  • 14 Poitrenaud J. Evaluation du niveau socioculturel. In : Hugonot-Diener L. (ed.). La consultation de gériatrie. Paris: Masson; 2001: 8-9
    Google Scholar
  • 15 Nasreddine ZS, Phillips NA, Bedirian V. et al. The montreal cognitive assessment, MoCA: A brief screening tool for mild cognitive impairment. J Am Geriatr Soc 2005; 53: 695-699
    CrossrefPubMedGoogle Scholar
  • 16 Crookes TG, McNair DM, Kahn RJ. Self-assessment of cognitive deficits. In: Kahn RJ, McNair DM, Crook T, Ferris A, Baltus R. (ed.). Assessment in geriatric psychopharmacology. New Canaan, Conn: Mark Powley Associates; 1983
    Google Scholar
  • 17 Brazier JE, Harper R, Jones NM. et al. Validating the SF-36 health survey questionnaire: New outcome measure for primary care. Br Med J 1992; 305: 160-164
    CrossrefPubMedGoogle Scholar
  • 18 Leplege A, Ecosse E, Verdier A. et al. The french SF-36 health survey: Translation, cultural adaptation and preliminary psychometric evaluation. J Clin Epidemiol 1998; 51: 1013-1023
    CrossrefPubMedGoogle Scholar
  • 19 Rosilio M, Berthezene F, Blum WF. et al. [The quality-of-life questionnaire QLS-H: Validation of the French language version of the questionnaire in patients with growth hormone deficiency and collection of reference data in the general population]. Ann Endocrinol 2004; 65: 439-450
    CrossrefPubMedGoogle Scholar
  • 20 Zigmond AS, Snaith RP. The hospital anxiety and depression scale. Acta Psychiatr Scand 1983; 67: 361-370
    Google Scholar
  • 21 Brummelman P, Elderson MF, Dullaart RP. et al. Cognitive functioning in patients treated for nonfunctioning pituitary macroadenoma and the effects of pituitary radiotherapy. Clin Endocrinol (Oxf) 2011; 74: 481-487
    CrossrefPubMedGoogle Scholar
  • 22 Brummelman P, Sattler MG, Meiners LC. et al. Cognitive performance after postoperative pituitary radiotherapy: A dosimetric study of the hippocampus and the prefrontal cortex. Eur J Endocrinol 2012; 166: 171-179
    CrossrefPubMedGoogle Scholar
  • 23 Page RC, Hammersley MS, Burke CW. et al. An account of the quality of life of patients after treatment for non-functioning pituitary tumours. Clin Endocrinol (Oxf) 1997; 46: 401-406
    CrossrefPubMedGoogle Scholar
  • 24 Johnson MD, Woodburn CJ, Vance ML. Quality of life in patients with a pituitary adenoma. Pituitary 2003; 6: 81-87
    CrossrefPubMedGoogle Scholar
  • 25 Capatina C, Christodoulides C, Fernandez A. et al. Current treatment protocols can offer a normal or near-normal quality of life in the majority of patients with non-functioning pituitary adenomas. Clin Endocrinol (Oxf) 2013; 78: 86-93
    CrossrefPubMedGoogle Scholar
  • 26 van der Klaauw AA, Kars M, Biermasz NR. et al. Disease-specific impairments in quality of life during long-term follow-up of patients with different pituitary adenomas. Clin Endocrinol (Oxf) 2008; 69: 775-784
    CrossrefPubMedGoogle Scholar
  • 27 Marvel CL, Paradiso S. Cognitive and neurological impairment in mood disorders. Psychiatr Clin N Am 2004; 27: 19-36
    CrossrefPubMedGoogle Scholar
  • 28 Kizilbash AH, Vanderploeg RD, Curtiss G. The effects of depression and anxiety on memory performance. Arch Clin Neuropsychol 2002; 17: 57-67
    CrossrefPubMedGoogle Scholar
  • 29 Iglesias P, Arcano K, Triviño V. et al. Prevalence, clinical features, and natural history of incidental clinically non-functioning pituitary adenomas. Horm Metab Res 2017; 49: 654-659
    Article in Thieme ConnectPubMedGoogle Scholar
  • 30 Cortet-Rudelli C, Bonneville JF, Borson-Chazot F. et al. Post-surgical management of non-functioning pituitary adenoma. Ann Endocrinol (Paris) 2015; 76: 228-238
    CrossrefPubMedGoogle Scholar
  • 31 Lee MH, Lee JH, Seol HJ. et al. Concerns about recurrence of non-functioning pituitary adenoma. Brain Tumor Res Treat 2016; 4: 1-7
    CrossrefPubMedGoogle Scholar
  • 32 Murad MH, Fernández-Balsells MM, Barwise A. et al. Outcomes of surgical treatment for nonfunctioning pituitary adenomas: A systematic review and meta-analysis. Clin Endocrinol (Oxf) 2010; 73: 777-791
    CrossrefPubMedGoogle Scholar
  • 33 Levy MJ, Robertson IJ, Khalk N. et al. Long-term follow-up of a large prospective cohort of patients with nonfunctioning pituitary adenomas: The outcome of a conservative management policy. Clin Endocrinol (Oxf) 2018; 89: 354-359
    CrossrefPubMedGoogle Scholar
  • 34 Lelotte J, Mourin A, Fomekong E. et al. Both invasiveness and proliferation criteria predict recurrence of non-functioningpituitary macroadenomas after surgery: A retrospective analysis of a monocentric cohort of 120 patients. Eur J Endocrinol 2018; 178: 237-246
    CrossrefPubMedGoogle Scholar
  • 35 Yamanaka R, Abe E, Sato T. et al. Secondary intracranial tumors following radiotherapy for pituitary adenomas: A systematic review. Cancers (Basel) 2017; 9 pii E103
    CrossrefPubMedGoogle Scholar
  • 36 Tiemensma J, Kokshoorn NE, Biermasz NR. et al. Subtle cognitive impairments in patients with long-term cure of Cushing's disease. J Clin Endocrinol Metab 2010; 95: 2699-2714
    CrossrefPubMedGoogle Scholar
  • 37 Lenehan ME, Summers MJ, Saunders NL. et al. Relationship between education and age-related cognitive decline: A review of recent research. Psychogeriatrics 2015; 5: 154-162
    PubMedGoogle Scholar
  • 38 Andela CD, Lobatto DJ, Pereira AM. et al. How non-functioning pituitary adenomas can affect health-related quality of life: A conceptual model and literature review. Pituitary 2018; 21: 208-216
    CrossrefPubMedGoogle Scholar